Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome
about
Dietary triggers in irritable bowel syndrome: Is there a role for glutenMechanism-Oriented Therapy of Irritable Bowel SyndromeReview article: bile acid diarrhoea - pathogenesis, diagnosis and managementEffects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.Therapeutic targeting of bile acidsReview article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.New and Investigational Agents for Irritable Bowel Syndrome.Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.Novel pharmacological therapies for irritable bowel syndrome.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Bile acid disease: the emerging epidemic.Antidiarrheal Drug Therapy.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline.Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.Pharmacotherapy for Irritable Bowel Syndrome.Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases.Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.Existing and emerging therapies for managing constipation and diarrhea.
P2860
Q26739974-BF52F8FB-0A48-4BEF-8396-FC75448DDA86Q26747875-4326AACF-2E9D-4F82-800F-018FA32CA86AQ28273649-1F8F9A10-BDCD-4DE2-9FE4-E540D4DB397AQ33632959-DE720B39-4675-48FB-BE91-D59E0DE0A786Q33855973-BE3EA0D7-5414-4A2F-A201-FE0F58F6DD3BQ35958534-41A1A5E5-22C6-456C-A9E5-9BFFAB15BD98Q36021269-F2DA3F17-1F15-4CED-8C4E-62913D7AB08EQ36082843-E4226E89-C37B-41CC-9BE9-C44D5A58E0C5Q36970524-61ED6B7A-055A-481C-8262-587C5AC883F2Q37632259-0BAD974A-AA17-49B6-AB72-85A12B639D72Q37699665-40ED32E4-5410-4178-BB62-4CC9FCBB597AQ38582664-8040F732-96F5-4E4F-ACA8-D1A5E095BC84Q38601834-1125BF3A-897C-42D4-9A1B-E360ED5A98C8Q38630721-A32D2DF2-8450-4F7A-8013-5F199E784335Q38747166-1A1E3C37-1716-4027-ADC5-902C8FEA0CEFQ38765085-B839BBCD-3B6A-4E58-BF0D-6E1BDCDC9692Q39124316-AACA4AE0-DBAF-454C-B3DB-0CF87929F469Q39233364-5A4AD20F-6908-4161-B602-F81D585CB680Q42695148-44481A85-7F19-4211-AEBD-D6F7D8521CBCQ43062026-0A91AFF7-F708-47E2-930D-E30C4B063021Q43913058-EB49CB7D-81EB-4C37-B216-B600877B9B79Q47117277-4C9DED7C-76A2-49EC-A12D-AC95CF8266FBQ47441583-21C9A096-FB3B-47D3-BA4D-2382208846B0Q48389586-CC7C4D23-E76C-4CA7-B36A-023591E5D2A4Q49677641-7123CAFA-9A51-4B2B-8005-B3CF1B94D123
P2860
Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@ast
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@en
type
label
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@ast
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@en
prefLabel
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@ast
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@en
P2093
P2860
P356
P1476
Effect of colesevelam on faeca ...... inant irritable bowel syndrome
@en
P2093
A Boldingh
I Busciglio
L J Donato
M Camilleri
P2860
P304
P356
10.1111/APT.13065
P407
P577
2015-01-16T00:00:00Z